Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 24499Erstellt: 26. Oktober 2026

Chlorosulfamic acid

Sulphamoyl chloride · Sulfamyl chloride · Chlorosulfonamide · Aminosulfonyl chloride · NSC 158265 · sulfamoyl chloride · Sulfamideoic chloride · Sulfamic acid chloride

https://huagongshe.com/de/chemical/24499

Molekülstruktur von Chlorosulfamic acid

Identifikatoren & physikalische Daten

CAS No.7778-42-9
SummenformelClH2NO2S
Durchschnittliche Molmasse115,54 g/mol
Monoisotopische Masse114,94947698 g/mol
SMILESNS(=O)(=O)Cl
InChIKeyQAHVHSLSRLSVGS-UHFFFAOYSA-N
PubChem CID24499
EC No.805-900-4
DTXSIDDTXSID30228396

Chemische & physikalische Eigenschaften

XLogP-0,3
Polarare Oberfläche (TPSA)68,5
H-Brücken-Donoren1
H-Brücken-Akzeptoren3
Frei drehbare Bindungen0
Schwere Atome5
Formalladung0
Komplexität95,3
SpringerMaterials PropertiesNuclear quadrupole resonance spectroscopy
Schmelzpunkt40-41℃
Siedepunkt100-105 °C(Press: 4 Torr)
Dichte1.787
Lagerbedingungen-20°C, protect from light, stored under nitrogen
LöslichkeitChloroform (Slightly), DMSO (Slightly)
Aggregatzustandsolid
pKa (Säurekonstante)6.82±0.60(Predicted)
FarbeOff White
StabilitätHygroscopic, Moisture sensitive
InChIInChI=1S/ClH2NO2S/c1-5(2,3)4/h(H2,2,3,4)
InChIKeyQAHVHSLSRLSVGS-UHFFFAOYSA-N
SMILESS(Cl)(N)(=O)=O
EPA chemische InformationenSulfamoyl chloride (7778-42-9)

Sicherheit & Vorschriften

GHS-EinstufungDangerH290 (50%): May be corrosive to metals [Warning Corrosive to Metals]P234, P260, P264, P264+P265, P270, P280, P301+P317, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P363, P390, P405, P406, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesMet. Corr. 1 (50%)
UN-TransportnummerUN3261
Zollcode2935909099
Gefahrenklasse8

Anwendungen & Verwendung

Verwenden

Sulfamoyl chloride is Used for the preparation of substituted glycoside sulfamates as anticonvulsant agents for the treatment of epilepsy.